Abstract
Mucus is an integral part of the respiratory physiology. It protects the respiratory tract by acting as a physical barrier against inhaled particles and microbes. Excessive inflammation in conditions such as COVID-19 can result in over-production of mucus which obstructs the airway. Build-up of mucus can also contribute to recurrent airway infection, causing further obstruction. This article summarizes the current understanding and knowledge of respiratory mucus production and proposes the role of cytokine storm in inducing sudden mucus hypersecretion in COVID-19. Based on these cascades, the active constituents that inhibit or activate several potential targets are outlined for further research. These may be explored for the discovery and design of drugs to combat cytokine storm and its ensuing complications.
Acknowledgments
The authors are grateful to Dr Shadab Raza and Dr Mohd. Faheem Khan for their advice in selection of journal for publication. We are also thankful to Dr. M.M.A. Faridi for the encouragement provided by him for the analytical approach of this review. Lastly, we thank the entire management of Era’s Lucknow Medical College & Hospital for supporting this work.
Disclosure
The authors report no conflicts of interest in this work.